Department of Plastic- and breastsurgery, Jonatan Damsgaard

Background

Immediate breast reconstruction (IBR) is one of the preferred procedures in risk reduction and early-stage cancer as it has several benefits for the patients. However, there may be surgical complications and the most frequent are skin necrosis, surgical site infections, implant loss and haematoma/seroma.

Purpose

To examine whether incisional negative pressure wound therapy (iNPWT) by the Prevena™ device, provides superior wound treatment compared with conventional wound therapy in patients undergoing  IBR.

Methods

The project is conducted as a randomized controlled trial where 30 patients are treated with Prevena™ and 30 patients are treated with conventional post-operative dressing.

Perspective

The results may be reduced length of hospitalization in women undergoing IBR, a better breast reconstructive result and reduced time to adjuvant therapy.